TD Asset Management Inc. reduced its position in shares of Henry Schein Inc. (NASDAQ:HSIC) by 28.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 211,041 shares of the company’s stock after selling 83,642 shares during the period. TD Asset Management Inc. owned 0.26% of Henry Schein worth $34,395,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in HSIC. Vanguard Group Inc. raised its position in Henry Schein by 2.2% in the second quarter. Vanguard Group Inc. now owns 7,493,463 shares of the company’s stock worth $1,324,844,000 after buying an additional 161,065 shares during the period. BlackRock Fund Advisors raised its position in Henry Schein by 2.4% in the second quarter. BlackRock Fund Advisors now owns 2,369,132 shares of the company’s stock worth $418,863,000 after buying an additional 55,384 shares during the period. Alecta Pensionsforsakring Omsesidigt raised its position in Henry Schein by 4.3% in the third quarter. Alecta Pensionsforsakring Omsesidigt now owns 2,103,590 shares of the company’s stock worth $342,864,000 after buying an additional 86,500 shares during the period. Janus Capital Management LLC raised its position in Henry Schein by 16.5% in the second quarter. Janus Capital Management LLC now owns 2,027,848 shares of the company’s stock worth $358,522,000 after buying an additional 286,929 shares during the period. Finally, UBS Asset Management Americas Inc. raised its position in Henry Schein by 55.7% in the second quarter. UBS Asset Management Americas Inc. now owns 802,401 shares of the company’s stock worth $141,865,000 after buying an additional 286,976 shares during the period. Institutional investors and hedge funds own 91.35% of the company’s stock.

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Henry Schein Inc. (NASDAQ:HSIC) traded up 0.902% during midday trading on Tuesday, hitting $152.725. The stock had a trading volume of 103,526 shares. The firm has a market cap of $12.29 billion, a P/E ratio of 25.361 and a beta of 1.09. Henry Schein Inc. has a 52 week low of $142.64 and a 52 week high of $183.00. The stock has a 50-day moving average of $154.22 and a 200-day moving average of $166.36.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Wednesday, November 2nd. The company reported $1.68 earnings per share for the quarter, topping analysts’ consensus estimates of $1.65 by $0.03. The company earned $2.87 billion during the quarter, compared to the consensus estimate of $2.88 billion. Henry Schein had a return on equity of 18.15% and a net margin of 4.40%. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.55 earnings per share. Analysts forecast that Henry Schein Inc. will post $6.58 EPS for the current fiscal year.

WARNING: “Henry Schein Inc. (HSIC) Position Decreased by TD Asset Management Inc.” was posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are reading this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark law. The legal version of this story can be viewed at https://www.thecerbatgem.com/2016/11/29/henry-schein-inc-hsic-position-decreased-by-td-asset-management-inc.html.

A number of equities analysts recently weighed in on HSIC shares. Zacks Investment Research lowered Henry Schein from a “hold” rating to a “sell” rating in a research report on Monday, August 8th. Bank of America Corp. initiated coverage on Henry Schein in a research report on Monday, September 12th. They set a “buy” rating and a $185.00 price objective for the company. Leerink Swann restated a “hold” rating on shares of Henry Schein in a research report on Thursday, November 3rd. Robert W. Baird restated an “outperform” rating and set a $176.00 price objective (up from $175.00) on shares of Henry Schein in a research report on Tuesday, October 4th. Finally, JPMorgan Chase & Co. restated a “hold” rating and set a $163.00 price objective on shares of Henry Schein in a research report on Thursday, November 3rd. Seven analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Henry Schein currently has an average rating of “Hold” and an average price target of $172.83.

In other news, EVP Mark E. Mlotek sold 2,417 shares of the business’s stock in a transaction on Thursday, November 3rd. The stock was sold at an average price of $155.19, for a total transaction of $375,094.23. Following the completion of the sale, the executive vice president now owns 40,456 shares in the company, valued at $6,278,366.64. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 1.27% of the company’s stock.

About Henry Schein

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

5 Day Chart for NASDAQ:HSIC

Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.